Hong Kong cases of ‘public enemy No 1’ superbug more than double in 2018, prompting Hospital Authority to unveil five-point plan to halt the spread
30 May 2019
Dr Raymond Lai Wai-man, chief infection control officer at the Hospital Authority, which manages the city’s 43 public hospitals and institutions, said the number of inpatients diagnosed with carbapenemase-producing enterobacteriaceae (CPE) last year was 972, a dramatic rise from 473 in 2017.
Further reading: South China Morning Post
Effective Surveillance
OUR UNDERWRITERS
Unrestricted financial support by:
 |
Antimicrobial Resistance Fighter Coalition |
 |
Evotec |
 |
JSS University |
 |
INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS |
Technology Database
Display your AMR Technology, Product and Service
Suppliers and Users of Technologies, Products and Services benefit from CAPI.
CAPI (Continuous AMR Partnering Initiative) unites Suppliers and Users worldwide with the aim to add to the curbing of AMR.
